Pd Rx Pharmaceutical Stock Technical Analysis
| PDRX Stock | USD 3.33 0.00 0.00% |
As of the 15th of February 2026, Pd-Rx Pharmaceutical owns the market risk adjusted performance of 2.28, and Information Ratio of 0.113. In respect to fundamental indicators, the technical analysis model allows you to check possible technical drivers of Pd Rx Pharmaceutical, as well as the relationship between them.
Pd-Rx Pharmaceutical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pd-Rx, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Pd-RxPd-Rx |
Pd-Rx Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pd-Rx Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pd-Rx Pharmaceutical.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Pd-Rx Pharmaceutical on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Pd Rx Pharmaceutical or generate 0.0% return on investment in Pd-Rx Pharmaceutical over 90 days. Pd-Rx Pharmaceutical is related to or competes with Unidoc Health, and Devonian Health. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the h... More
Pd-Rx Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pd-Rx Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pd Rx Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.113 | |||
| Maximum Drawdown | 14.83 |
Pd-Rx Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pd-Rx Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pd-Rx Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Pd-Rx Pharmaceutical historical prices to predict the future Pd-Rx Pharmaceutical's volatility.| Risk Adjusted Performance | 0.1274 | |||
| Jensen Alpha | 0.2612 | |||
| Total Risk Alpha | 0.1313 | |||
| Treynor Ratio | 2.27 |
Pd-Rx Pharmaceutical February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1274 | |||
| Market Risk Adjusted Performance | 2.28 | |||
| Mean Deviation | 0.5313 | |||
| Coefficient Of Variation | 662.58 | |||
| Standard Deviation | 1.84 | |||
| Variance | 3.4 | |||
| Information Ratio | 0.113 | |||
| Jensen Alpha | 0.2612 | |||
| Total Risk Alpha | 0.1313 | |||
| Treynor Ratio | 2.27 | |||
| Maximum Drawdown | 14.83 | |||
| Skewness | 7.81 | |||
| Kurtosis | 62.27 |
Pd Rx Pharmaceutical Backtested Returns
Pd-Rx Pharmaceutical appears to be slightly risky, given 3 months investment horizon. Pd Rx Pharmaceutical retains Efficiency (Sharpe Ratio) of 0.15, which implies the firm had a 0.15 % return per unit of price deviation over the last 3 months. We have found sixteen technical indicators for Pd-Rx Pharmaceutical, which you can use to evaluate the volatility of the company. Please evaluate Pd-Rx Pharmaceutical's information ratio of 0.113, and Market Risk Adjusted Performance of 2.28 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pd-Rx Pharmaceutical holds a performance score of 12. The company owns a Beta (Systematic Risk) of 0.12, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pd-Rx Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pd-Rx Pharmaceutical is expected to be smaller as well. Please check Pd-Rx Pharmaceutical's risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to make a quick decision on whether Pd-Rx Pharmaceutical's current price history will revert.
Auto-correlation | 0.31 |
Below average predictability
Pd Rx Pharmaceutical has below average predictability. Overlapping area represents the amount of predictability between Pd-Rx Pharmaceutical time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pd Rx Pharmaceutical price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Pd-Rx Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Pd-Rx Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Pd Rx Pharmaceutical Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Pd Rx Pharmaceutical across different markets.
About Pd-Rx Pharmaceutical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pd Rx Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pd Rx Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pd Rx Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Pd Rx Pharmaceutical. By analyzing Pd-Rx Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pd-Rx Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pd-Rx Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pd-Rx Pharmaceutical February 15, 2026 Technical Indicators
Most technical analysis of Pd-Rx help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pd-Rx from various momentum indicators to cycle indicators. When you analyze Pd-Rx charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1274 | |||
| Market Risk Adjusted Performance | 2.28 | |||
| Mean Deviation | 0.5313 | |||
| Coefficient Of Variation | 662.58 | |||
| Standard Deviation | 1.84 | |||
| Variance | 3.4 | |||
| Information Ratio | 0.113 | |||
| Jensen Alpha | 0.2612 | |||
| Total Risk Alpha | 0.1313 | |||
| Treynor Ratio | 2.27 | |||
| Maximum Drawdown | 14.83 | |||
| Skewness | 7.81 | |||
| Kurtosis | 62.27 |
Pd-Rx Pharmaceutical February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Pd-Rx stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 3.33 | ||
| Day Typical Price | 3.33 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Pd-Rx Pink Sheet Analysis
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.